Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
24 "Thyroid gland"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Calcium & bone metabolism
Parathyroid Gland Generation from Pluripotent Stem Cells
Mayuko Kano
Endocrinol Metab. 2024;39(4):552-558.   Published online June 10, 2024
DOI: https://doi.org/10.3803/EnM.2024.1989
  • 1,528 View
  • 71 Download
AbstractAbstract PDFPubReader   ePub   
Patients with permanent hypoparathyroidism require lifelong treatment. Current replacement therapies sometimes have adverse effects (e.g., hypercalciuria and chronic kidney disease). Generating parathyroid glands (PTGs) from the patient’s own induced pluripotent stem cells (PSCs), with transplantation of these PTGs, would be an effective treatment option. Multiple methods for generating PTGs from PSCs have been reported. One major trend is in vitro differentiation of PSCs into PTGs. Another is in vivo generation of PSC-derived PTGs by injecting PSCs into PTG-deficient embryos. This review discusses current achievements and challenges in present and future PTG regenerative medicine.
Close layer
Special Article
Miscellaneous
Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim, The Committee of Clinical Practice Guideline of the Korean Endocrine Society
Endocrinol Metab. 2022;37(6):839-850.   Published online December 26, 2022
DOI: https://doi.org/10.3803/EnM.2022.1627
  • 4,592 View
  • 341 Download
  • 2 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Immune checkpoint inhibitors (ICIs) including an anti-cytotoxic T-lymphocyte-associated antigen 4 inhibitor, anti-programmed cell death protein 1 (PD-1) inhibitors, and anti-PD-ligand 1 inhibitors are representative therapeutics for various malignancies. In oncology, the application of ICIs is currently expanding to a wider range of malignancies due to their remarkable clinical outcomes. ICIs target immune checkpoints which suppress the activity of T-cells that are specific for tumor antigens, thereby allowing tumor cells to escape the immune response. However, immune checkpoints also play a crucial role in preventing autoimmune reactions. Therefore, ICIs targeting immune checkpoints can trigger various immune-related adverse events (irAEs), especially in endocrine organs. Considering the endocrine organs that are frequently involved, irAEs associated endocrinopathies are frequently life-threatening and have unfavorable clinical implications for patients. However, there are very limited data from large clinical trials that would inform the development of clinical guidelines for patients with irAEs associated endocrinopathies. Considering the current clinical situation, in which the scope and scale of the application of ICIs are increasing, position statements from clinical specialists play an essential role in providing the appropriate recommendations based on both medical evidence and clinical experience. As endocrinologists, we would like to present precautions and recommendations for the management of immune-related endocrine disorders, especially those involving the adrenal, thyroid, and pituitary glands caused by ICIs.

Citations

Citations to this article as recorded by  
  • Patterns of hormonal changes in hypophysitis by immune checkpoint inhibitor
    Hyunji Sang, Yun Kyung Cho, Sang-hyeok Go, Hwa Jung Kim, Eun Hee Koh
    The Korean Journal of Internal Medicine.2024; 39(5): 801.     CrossRef
  • Pembrolizumab plus lenvatinib for radically unresectable or metastatic renal cell carcinoma in the Japanese population
    Ryo Fujiwara, Takeshi yuasa, kenichi kobayashi, tetsuya yoshida, susumu kageyama
    Expert Review of Anticancer Therapy.2023; 23(5): 461.     CrossRef
  • Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review
    Won Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, Hwa Young Ahn
    Endocrinology and Metabolism.2023; 38(6): 750.     CrossRef
Close layer
Review Article
Thyroid
Euthyroid Thyroperoxidase Antibody Positivity during Pregnancy, to Treat or Not to Treat?
Tim I. M. Korevaar
Endocrinol Metab. 2022;37(3):387-391.   Published online June 29, 2022
DOI: https://doi.org/10.3803/EnM.2022.301
  • 4,167 View
  • 214 Download
  • 2 Web of Science
  • 4 Crossref
AbstractAbstract PDFPubReader   ePub   
Thyroperoxidase antibody (TPOAb) positivity is a well-known risk factor for thyroid dysfunction during pregnancy and is associated with a suboptimal response to thyroidal stimulation by human chorionic gonadotropin. About 75% of TPOAb positive women are euthyroid and there seems to be a higher risk of predominantly miscarriage and preterm birth in this subgroup. Nonetheless, clinical decision making with regards to gestational levothyroxine treatment remains difficult due to a lack of large randomized trials. Future studies assessing dose-dependent associations and additional biomarkers that can distinguish low-risk from high-risk individuals will be key in disentangling the crude clinical data.

Citations

Citations to this article as recorded by  
  • Thyroid autoimmunity and adverse pregnancy outcomes: A multiple center retrospective study
    Yun Xu, Hui Chen, Meng Ren, Yu Gao, Kan Sun, Hongshi Wu, Rui Ding, Junhui Wang, Zheqing Li, Dan Liu, Zilian Wang, Li Yan
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The Clinical Implications of Anti-thyroid Peroxidase Antibodies in Graves’ Disease in Basrah
    Emad S Alhubaish, Nassar T Alibrahim, Abbas A Mansour
    Cureus.2023;[Epub]     CrossRef
  • Research Progress on the Influence of Autoimmune Thyroid Disease on Pregnancy Outcome
    敏 李
    Advances in Clinical Medicine.2023; 13(08): 13720.     CrossRef
  • The Impact of Maternal Hypothyroidism during Pregnancy on Minipuberty in Boys
    Karolina Kowalcze, Robert Krysiak, Anna Obuchowicz
    Journal of Clinical Medicine.2023; 12(24): 7649.     CrossRef
Close layer
Original Articles
Thyroid
Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors
David Tak Wai Lui, Chi Ho Lee, Wing Sun Chow, Alan Chun Hong Lee, Anthony Raymond Tam, Carol Ho Yi Fong, Chun Yiu Law, Eunice Ka Hong Leung, Kelvin Kai Wang To, Kathryn Choon Beng Tan, Yu Cho Woo, Ching Wan Lam, Ivan Fan Ngai Hung, Karen Siu Ling Lam
Endocrinol Metab. 2021;36(3):582-589.   Published online June 8, 2021
DOI: https://doi.org/10.3803/EnM.2021.983
  • 12,138 View
  • 282 Download
  • 34 Web of Science
  • 36 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The occurrence of Graves’ disease and Hashimoto thyroiditis after coronavirus disease 2019 (COVID-19) raised concerns that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may trigger thyroid autoimmunity. We aimed to address the current uncertainties regarding incident thyroid dysfunction and autoimmunity among COVID-19 survivors.
Methods
We included consecutive adult COVID-19 patients without known thyroid disorders, who were admitted to Queen Mary Hospital from July 21 to September 21, 2020 and had serum levels of thyroid-stimulating hormone, free thyroxine, free triiodothyronine (fT3), and anti-thyroid antibodies measured both on admission and at 3 months.
Results
In total, 122 patients were included. Among 20 patients with abnormal thyroid function tests (TFTs) on admission (mostly low fT3), 15 recovered. Among 102 patients with initial normal TFTs, two had new-onset abnormalities that could represent different phases of thyroiditis. Among 104 patients whose anti-thyroid antibody titers were reassessed, we observed increases in anti-thyroid peroxidase (TPO) (P<0.001) and anti-thyroglobulin (P<0.001), but not anti-thyroid stimulating hormone receptor titers (P=0.486). Of 82 patients with negative anti-TPO findings at baseline, 16 had a significant interval increase in anti-TPO titer by >12 U, and four became anti-TPO-positive. Worse baseline clinical severity (P=0.018), elevated C-reactive protein during hospitalization (P=0.033), and higher baseline anti-TPO titer (P=0.005) were associated with a significant increase in anti-TPO titer.
Conclusion
Most patients with thyroid dysfunction on admission recovered during convalescence. Abnormal TFTs suggestive of thyroiditis occurred during convalescence, but infrequently. Importantly, our novel observation of an increase in anti-thyroid antibody titers post-COVID-19 warrants further follow-up for incident thyroid dysfunction among COVID-19 survivors.

Citations

Citations to this article as recorded by  
  • The prevalence of thyroid disorders in COVID-19 patients: a systematic review and meta-analysis
    Sadra Ashrafi, Hossein Hatami, Razieh Bidhendi-Yarandi, Mohammad Hossein Panahi
    BMC Endocrine Disorders.2024;[Epub]     CrossRef
  • Does COVID-19 affect thyroid more than non-COVID-19 infections? A retrospective study
    Yasemin Ucal, Muhittin Serdar, Hande Karpuzoğlu, Neval Yurttutan Uyar, Meltem Kilercik, Mustafa Serteser, Aysel Ozpinar
    Turkish Journal of Biochemistry.2024; 49(2): 227.     CrossRef
  • Thyroiditis and COVID-19: focus on pediatric age. A narrative review
    F. d’Aniello, M. E. Amodeo, A. Grossi, G. Ubertini
    Journal of Endocrinological Investigation.2024; 47(7): 1633.     CrossRef
  • Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection
    Keisuke Murakawa, Hiroaki Aasi, Kanako Sato, Saori Yoshioka, Hiroyuki Sho, Ryoko Inui, Motohiro Kosugi, Yoji Hazama, Tetsuyuki Yasuda
    Diabetology International.2024; 15(3): 621.     CrossRef
  • Prevalence and factors associated with thyroid autoimmunity among children newly diagnosed with type 1 diabetes before and during the COVID‐19 pandemic: Evidence from Kuwait
    Dalia Al‐Abdulrazzaq, Ahmed Najeeb Albatineh, Doaa Khalifa, Anwaar Alrefae, Ebaa Al‐Awadhi, Abdullah Alkandari, Doha Alhomaidah, Solveig Argeseanu Cunningham, Hessa Al‐Kandari
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • The most common persistent symptoms in patients with COVID-19 who were evaluated in the Internal Medicine polyclinic
    Zeynep KOÇ, Seydahmet AKIN
    The European Research Journal.2023; 9(1): 97.     CrossRef
  • Clinical assessment of children with long COVID syndrome
    Réka Garai, Péter Krivácsy, Vivien Herczeg, Fanni Kovács, Bálint Tél, Judit Kelemen, Anna Máthé, Eszter Zsáry, Johanna Takács, Dániel Sándor Veres, Attila J. Szabó
    Pediatric Research.2023; 93(6): 1616.     CrossRef
  • T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens
    Robert Root-Bernstein, Elizabeth Churchill, Shelby Oliverio
    International Journal of Molecular Sciences.2023; 24(2): 1335.     CrossRef
  • A Literature Review on SARS-CoV-2 and Other Viruses in Thyroid Disorders: Environmental Triggers or No-Guilty Bystanders?
    Francesca Gorini, Cristina Vassalle
    International Journal of Environmental Research and Public Health.2023; 20(3): 2389.     CrossRef
  • Thyroid dysfunction as a long-term post-COVID-19 complication in mild-to-moderate COVID-19
    Vesselina Yanachkova, Teodora Stankova, Radiana Staynova
    Biotechnology & Biotechnological Equipment.2023; 37(1): 194.     CrossRef
  • The Influence of SARS-CoV-2 Infection on the Thyroid Gland
    Aleksandra Piekarska, Marta Góral, Marta Kozula, Aleksandra Jawiarczyk-Przybyłowska, Katarzyna Zawadzka, Marek Bolanowski
    Biomedicines.2023; 11(2): 614.     CrossRef
  • Thyroid Function Abnormalities and Outcomes in Hospitalized Patients with COVID-19 Infection: A Cross-Sectional Study
    Deepika Patel, Dukhabandhu Naik, Sadishkumar Kamalanathan, Kadhiravan Tamilarasu, Jayaprakash Sahoo, Ayan Roy, Chandhana Merugu, Varun Suryadevara
    Hormone and Metabolic Research.2023; 55(03): 169.     CrossRef
  • The Spectrum of Thyroid Function Tests and Autoantibodies During Hospitalization and After Six Months of Discharge in COVID-19 Patients: Does COVID-19 Trigger Autoimmunity?
    Ziynet Alphan Uc, Pinar Yagcı, Zelal Adibelli, Cevdet Duran
    Endocrine Research.2023; 48(2-3): 44.     CrossRef
  • Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study
    Alessandro Rossini, Sara Cassibba, Francesca Perticone, Simone Vasilij Benatti, Serena Venturelli, Greta Carioli, Arianna Ghirardi, Marco Rizzi, Tiziano Barbui, Roberto Trevisan, Silvia Ippolito
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • A prospective follow-up of thyroid volume and thyroiditis features on ultrasonography among survivors of predominantly mild to moderate COVID-19
    Man Him Matrix Fung, David Tak Wai Lui, Keith Wan Hang Chiu, Sherman Haynam Lee, Chi Ho Lee, Wing Sun Chow, Alan Chun Hong Lee, Anthony Raymond Tam, Polly Pang, Tip Yin Ho, Carol Ho Yi Fong, Connie Hong Nin Loong, Chun Yiu Law, Kelvin Kai Wang To, Ching W
    PeerJ.2023; 11: e15034.     CrossRef
  • Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease
    Jie Li, Yonghong Liu, Jian Jin, Qingfeng Shi, Yanting Ji, Bo Zhang, Pengfei Hu, Jinghua Pan
    Mediators of Inflammation.2023; 2023: 1.     CrossRef
  • Beyond Acute COVID-19: Investigating the Incidence of Subacute Thyroiditis in Long COVID-19 in Korea
    Jeongmin Lee, Gi Hyeon Seo, Keeho Song
    Endocrinology and Metabolism.2023; 38(4): 455.     CrossRef
  • Thyroid Autoimmunity and SARS-CoV-2 Infection
    Poupak Fallahi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Eugenia Balestri, Valeria Mazzi, Salvatore Benvenga, Gilda Varricchi, Laura Gragnani, Chiara Botrini, Enke Baldini, Marco Centanni, Clodoveo Ferri, Alessandro Antonell
    Journal of Clinical Medicine.2023; 12(19): 6365.     CrossRef
  • Autoimmune complications of COVID‐19
    Niloufar Yazdanpanah, Nima Rezaei
    Journal of Medical Virology.2022; 94(1): 54.     CrossRef
  • The Independent Association of TSH and Free Triiodothyronine Levels With Lymphocyte Counts Among COVID-19 Patients
    David Tak Wai Lui, Chi Ho Lee, Wing Sun Chow, Alan Chun Hong Lee, Anthony Raymond Tam, Polly Pang, Tip Yin Ho, Chloe Yu Yan Cheung, Carol Ho Yi Fong, Chun Yiu Law, Kelvin Kai Wang To, Ching Wan Lam, Kathryn Choon Beng Tan, Yu Cho Woo, Ivan Fan Ngai Hung,
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Comment on Khunti et al. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021;44:2645–2655
    Carmine Gazzaruso, Adriana Coppola, Pietro Gallotti, Ileana Terruzzi, Tiziana Montalcini, Livio Luzi
    Diabetes Care.2022; 45(2): e45.     CrossRef
  • The potential impact of COVID-19 on thyroid gland volumes among COVID-19 survivors
    Emre Urhan, Zuleyha Karaca, Canan Sehit Kara, Zeynep Ture Yuce, Kursad Unluhizarci
    Endocrine.2022; 76(3): 635.     CrossRef
  • Systematic review of COVID-19 and autoimmune thyroiditis
    Esra Tutal, Resat Ozaras, Hakan Leblebicioglu
    Travel Medicine and Infectious Disease.2022; 47: 102314.     CrossRef
  • The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine
    Mihaela Popescu, Adina Ghemigian, Corina Maria Vasile, Andrei Costache, Mara Carsote, Alice Elena Ghenea
    Diagnostics.2022; 12(4): 960.     CrossRef
  • Should we expect a wave of type 1 diabetes following SARS‐CoV‐2 pandemic?
    Laura Montefusco, Andrea Mario Bolla, Paolo Fiorina
    Diabetes/Metabolism Research and Reviews.2022;[Epub]     CrossRef
  • COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study
    Gloria Hoi-Yee Li, Ching-Man Tang, Ching-Lung Cheung
    Thyroid.2022; 32(9): 1037.     CrossRef
  • Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients
    D. T. W. Lui, C. H. Lee, W. S. Chow, A. C. H. Lee, A. R. Tam, C. Y. Y. Cheung, C. H. Y. Fong, S. T. M. Kwok, C. Y. Law, K. K. W. To, C. W. Lam, K. C. B. Tan, Y. C. Woo, I. F. N. Hung, K. S. L. Lam
    Journal of Endocrinological Investigation.2022; 45(11): 2149.     CrossRef
  • Symptomatic Bradycardia Manifesting as Acute Hypothyroidism Following COVID-19 Infection: A Case Report
    Jaydip Desai, Arsh N Patel, Courtney L Evans, Molly Triggs, Fulton Defour
    Cureus.2022;[Epub]     CrossRef
  • Schilddrüse und SARS-CoV-2
    Georg Zettinig
    Journal für Klinische Endokrinologie und Stoffwechsel.2022; 15(3): 100.     CrossRef
  • Thyroid diseases are associated with coronavirus disease 2019 infection
    Yutian Tian, Junyu Zhao, Tingting Wang, Haipeng Wang, Jinming Yao, Song Wang, Yaru Mou
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Thyrotropin Levels in Patients with Coronavirus Disease 2019: Assessment during Hospitalization and in the Medium Term after Discharge
    Abdallah Al-Salameh, Noémie Scherman, Imane Adda, Juliette André, Yoann Zerbib, Julien Maizel, Jean-Daniel Lalau, Etienne Brochot, Claire Andrejak, Rachel Desailloud
    Life.2022; 12(12): 2014.     CrossRef
  • Long COVID in Patients With Mild to Moderate Disease: Do Thyroid Function and Autoimmunity Play a Role?
    David Tak Wai Lui, Chi Ho Lee, Wing Sun Chow, Alan Chun Hong Lee, Anthony Raymond Tam, Polly Pang, Tip Yin Ho, Carol Ho Yi Fong, Chun Yiu Law, Eunice Ka Hong Leung, Kelvin Kai Wang To, Kathryn Choon Beng Tan, Yu Cho Woo, Ching Wan Lam, Ivan Fan Ngai Hung,
    Endocrine Practice.2021; 27(9): 894.     CrossRef
  • Hashimoto’s thyroiditis following SARS-CoV-2 infection
    Rafael Silvestre Knack, Taliê Hanada, Renata Silvestre Knack, Kamilla Mayr
    BMJ Case Reports.2021; 14(8): e244909.     CrossRef
  • Higher SARS-CoV-2 viral loads correlated with smaller thyroid volumes on ultrasound among male COVID-19 survivors
    David Tak Wai Lui, Matrix Man Him Fung, Keith Wan Hang Chiu, Chi Ho Lee, Wing Sun Chow, Alan Chun Hong Lee, Anthony Raymond Tam, Polly Pang, Tip Yin Ho, Carol Ho Yi Fong, Connie Hong Nin Loong, Wade Wei Wong, Cassandra Yuen Yan Lee, Chun Yiu Law, Kelvin K
    Endocrine.2021; 74(2): 205.     CrossRef
  • SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
    Avaniyapuram Kannan Murugan, Ali S Alzahrani
    Journal of Inflammation Research.2021; Volume 14: 6191.     CrossRef
  • POST-COVID ENDOCRINOPATHY :ABOUT A CASE ENDOCRINOPATHIE POST- COVID :À PROPOS D’UN CAS
    S. Rafi, G. Elmghari, N, Elansari
    INDIAN JOURNAL OF APPLIED RESEARCH.2021; : 13.     CrossRef
Close layer
Endocrine Research
DEHP Down-Regulates Tshr Gene Expression in Rat Thyroid Tissues and FRTL-5 Rat Thyrocytes: A Potential Mechanism of Thyroid Disruption
Min Joo Kim, Hwan Hee Kim, Young Shin Song, Ok-Hee Kim, Kyungho Choi, Sujin Kim, Byung-Chul Oh, Young Joo Park
Endocrinol Metab. 2021;36(2):447-454.   Published online March 31, 2021
DOI: https://doi.org/10.3803/EnM.2020.920
  • 5,923 View
  • 156 Download
  • 12 Web of Science
  • 14 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Di-2-ethylhexyl phthalate (DEHP) is known to disrupt thyroid hormonal status. However, the underlying molecular mechanism of this disruption is unclear. Therefore, we investigated the direct effects of DEHP on the thyroid gland.
Methods
DEHP (vehicle, 50 mg/kg, and 500 mg/kg) was administered to Sprague-Dawley rats for 2 weeks. The expression of the thyroid hormone synthesis pathway in rat thyroid tissues was analyzed through RNA sequencing analysis, quantitative reverse transcription-polymerase chain reaction (RT-PCR), and immunohistochemical (IHC) staining. DEHP was treated to FRTL-5 rat thyroid cells, and an RT-PCR analysis was performed. A reporter gene assay containing the promoter of thyroid stimulating hormone receptor (TSHR) in Nthy-ori 3-1 human thyroid cells was constructed, and luciferase activity was determined.
Results
After DEHP treatment, the free thyroxine (T4) and total T4 levels in rats significantly decreased. RNA sequencing analysis of rat thyroid tissues showed little difference between vehicle and DEHP groups. In the RT-PCR analysis, Tshr expression was significantly lower in both DEHP groups (50 and 500 mg/kg) compared to that in the vehicle group, and IHC staining showed that TSHR expression in the 50 mg/kg DEHP group significantly decreased. DEHP treatment to FRTL-5 cells significantly down-regulated Tshr expression. DEHP treatment also reduced luciferase activity in a reporter gene assay for TSHR.
Conclusion
Although overall genetic changes in the thyroid hormone synthesis pathway are not clear, DEHP exposure could significantly down-regulate Tshr expression in thyroid glands. Down-regulation of Tshr gene appears to be one of potential mechanisms of thyroid disruption by DEHP exposure.

Citations

Citations to this article as recorded by  
  • ARTS is essential for di-2-ethylhexyl phthalate (DEHP)-induced apoptosis of mouse Leydig cells
    Yue Li, Linlin Xu, Chaoju Hao, Si Yang, Jinglei Wang, Jiaxiang Chen
    Ecotoxicology and Environmental Safety.2024; 270: 115882.     CrossRef
  • Thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review
    Jie He, Jie Xu, Mucong Zheng, Kai Pan, Lilin Yang, Lina Ma, Chuyang Wang, Jie Yu
    Chemico-Biological Interactions.2024; 391: 110909.     CrossRef
  • Maternal Thyroid Hormones as Mediators between Phthalate Exposure and Neonatal Birth Weight: A Cross-Sectional Study from the Zunyi Birth Cohort
    Lin Tao, Dengqing Liao, Shimin Xiong, Lulu Dai, Yuan-zhong Zhou, Xubo Shen
    Environment & Health.2024;[Epub]     CrossRef
  • Thyroid under Attack: The Adverse Impact of Plasticizers, Pesticides, and PFASs on Thyroid Function
    Vinicius Gonçalves Rodrigues, Guilherme Henrique, Érica Kássia Sousa-Vidal, Rafaela Martins Miguel de Souza, Evelyn Franciny Cardoso Tavares, Nathana Mezzalira, Thacila de Oliveira Marques, Bruna Monteiro Alves, João Anthony Araújo Pinto, Luana Naomi Niwa
    Endocrines.2024; 5(3): 430.     CrossRef
  • Intrauterine exposure to di(2-ethylhexyl) phthalate (DEHP) disrupts the function of the hypothalamus-pituitary-thyroid axis of the F1 rats during adult life
    Érica Kássia Sousa-Vidal, Guilherme Henrique, Renata Elen Costa da Silva, Caroline Serrano-Nascimento
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Drinking water disinfection byproduct iodoacetic acid affects thyroid hormone synthesis in Nthy-ori 3–1 cells
    Jingyi Xiao, Yujie Sha, Yuwen Huang, Kunling Long, Huan Wu, Yan Mo, Qiyuan Yang, Shengkun Dong, Qiang Zeng, Xiao Wei
    Ecotoxicology and Environmental Safety.2023; 257: 114926.     CrossRef
  • Assessment of five typical environmental endocrine disruptors and thyroid cancer risk: a meta-analysis
    Yuyao Yang, Xiaoyue Bai, Juan Lu, Ronghao Zou, Rui Ding, Xiaohui Hua
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Investigation of the effects of phthalates on in vitro thyroid models with RNA-Seq and ATAC-Seq
    Marta Nazzari, Mírian Romitti, Duncan Hauser, Daniel J. Carvalho, Stefan Giselbrecht, Lorenzo Moroni, Sabine Costagliola, Florian Caiment
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Di(2-ethylhexyl) phthalate (DEHP) and thyroid: biological mechanisms of interference and possible clinical implications
    Xueting Zhang, Wen Qi, Qi Xu, Xu Li, Liting Zhou, Lin Ye
    Environmental Science and Pollution Research.2022; 29(2): 1634.     CrossRef
  • The possible thyroid disruptive effect of di-(2-ethyl hexyl) phthalate and the potential protective role of selenium and curcumin nanoparticles: a toxicological and histological study
    Naima Abd El-Halim Sherif, Asmaa El-Banna, Rehab Ahmed Abdel-Moneim, Zahraa Khalifa Sobh, Manal Ibrahim Fathy Balah
    Toxicology Research.2022; 11(1): 108.     CrossRef
  • Environmental disruption of reproductive rhythms
    Marie-Azélie Moralia, Clarisse Quignon, Marine Simonneaux, Valérie Simonneaux
    Frontiers in Neuroendocrinology.2022; 66: 100990.     CrossRef
  • Endocrine-disruptor endpoints in the ovary and thyroid of adult female rats exposed to realistic doses of di-(2-ethylhexyl) phthalate
    Amel Jebara, Asma Beltifa, Guissepa Di Bella, Lotfi Mabrouk, Hedi Ben Mansour
    Journal of Water and Health.2022; 20(8): 1256.     CrossRef
  • The influence of sunitinib and sorafenib, two tyrosine kinase inhibitors, on development and thyroid system in zebrafish larvae
    Gang Wei, Cao-xu Zhang, Yu Jing, Xia Chen, Huai-dong Song, Liu Yang
    Chemosphere.2022; 308: 136354.     CrossRef
  • Role of estrogen receptors in thyroid toxicity induced by mono (2-ethylhexyl) phthalate via endoplasmic reticulum stress: An in vitro mechanistic investigation
    Qi Xu, Liting Zhou, Hyonju Ri, Xu Li, Xueting Zhang, Wen Qi, Lin Ye
    Environmental Toxicology and Pharmacology.2022; 96: 104007.     CrossRef
Close layer
Review Articles
Miscellaneous
Rare PTH Gene Mutations Causing Parathyroid Disorders: A Review
Joon-Hyop Lee, Munkhtugs Davaatseren, Sihoon Lee
Endocrinol Metab. 2020;35(1):64-70.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.64
  • 5,736 View
  • 121 Download
  • 9 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   ePub   

Since parathyroid hormone (PTH) was first isolated and its gene (PTH) was sequenced, only eight PTH mutations have been discovered. The C18R mutation in PTH, discovered in 1990, was the first to be reported. This autosomal dominant mutation induces endoplasmic reticulum stress and subsequent apoptosis in parathyroid cells. The next mutation, which was reported in 1992, is associated with exon skipping. The substitution of G with C in the first nucleotide of the second intron results in the exclusion of the second exon; since this exon includes the initiation codon, translation initiation is prevented. An S23P mutation and an S23X mutation at the same residue were reported in 1999 and 2012, respectively. Both mutations resulted in hypoparathyroidism. In 2008, a somatic R83X mutation was detected in a parathyroid adenoma tissue sample collected from a patient with hyperparathyroidism. In 2013, a heterozygous p.Met1_Asp6del mutation was incidentally discovered in a case-control study. Two years later, the R56C mutation was reported; this is the only reported hypoparathyroidism-causing mutation in the mature bioactive part of PTH. In 2017, another heterozygous mutation, M14K, was detected. The discovery of these eight mutations in the PTH gene has provided insights into its function and broadened our understanding of the molecular mechanisms underlying mutation progression. Further attempts to detect other such mutations will help elucidate the functions of PTH in a more sophisticated manner.

Citations

Citations to this article as recorded by  
  • The Intricacies of Renal Phosphate Reabsorption—An Overview
    Valerie Walker
    International Journal of Molecular Sciences.2024; 25(9): 4684.     CrossRef
  • Molecular and Clinical Spectrum of Primary Hyperparathyroidism
    Smita Jha, William F Simonds
    Endocrine Reviews.2023; 44(5): 779.     CrossRef
  • Rare cause of persistent hypocalcaemia in infancy due to PTH gene mutation
    Savita Khadse, Vrushali Satish Takalikar, Radha Ghildiyal, Nikhil Shah
    BMJ Case Reports.2023; 16(9): e256358.     CrossRef
  • Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone
    Patrick Hanna, Ashok Khatri, Shawn Choi, Severine Brabant, Matti L. Gild, Marie L. Piketty, Bruno Francou, Dominique Prié, John T. Potts, Roderick J. Clifton-Bligh, Agnès Linglart, Thomas J. Gardella, Harald Jüppner
    Proceedings of the National Academy of Sciences.2023;[Epub]     CrossRef
  • Genetics of monogenic disorders of calcium and bone metabolism
    Paul J. Newey, Fadil M. Hannan, Abbie Wilson, Rajesh V. Thakker
    Clinical Endocrinology.2022; 97(4): 483.     CrossRef
  • Homozygous missense variant of PTH (c.166C>T, p.(Arg56Cys)) as the cause of familial isolated hypoparathyroidism in a three-year-old child
    Stine Linding Andersen, Anja Lisbeth Frederiksen, Astrid Bruun Rasmussen, Mette Madsen, Ann-Margrethe Rønholt Christensen
    Journal of Pediatric Endocrinology and Metabolism.2022; 35(5): 691.     CrossRef
  • Novel PTH Gene Mutations Causing Isolated Hypoparathyroidism
    Colin P Hawkes, Jamal M Al Jubeh, Dong Li, Susan E Tucker, Tara Rajiyah, Michael A Levine
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(6): e2449.     CrossRef
Close layer
Miscellaneous
Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism
Zahra F. Khan, John I. Lew
Endocrinol Metab. 2019;34(4):327-339.   Published online December 23, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.4.327
  • 6,350 View
  • 138 Download
  • 27 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   ePub   

Intraoperative parathyroid hormone monitoring (IPM) has been shown to be a useful adjunct during parathyroidectomy to ensure operative success at many specialized medical centers worldwide. Using the Miami or “>50% intraoperative PTH drop” criterion, IPM confirms the complete excision of all hyperfunctioning parathyroid tissue before the operation is finished, and helps guide the surgeon to identify additional hyperfunctioning parathyroid glands that may necessitate further extensive neck exploration when intraoperative parathyroid hormone (PTH) levels do not drop sufficiently. The intraoperative PTH assay is also used to differentiate parathyroid from non-parathyroid tissues during operations using fine needle aspiration samples and to lateralize the side of the neck harboring the hypersecreting parathyroid through differential jugular venous sampling when preoperative localization studies are negative or equivocal. The use of IPM underscores the recognition and understanding of sporadic primary hyperparathyroidism (SPHPT) as a disease of function rather than form, where the surgeon is better equipped to treat such patients with quantitative instead of qualitative information for durable long-term operative success. There has been a significant paradigm shift over the last 2 decades from conventional to focused parathyroidectomy guided by IPM. This approach has proven to be a safe and rapid operation requiring minimal dissection performed in an ambulatory setting for the treatment of SPHPT.

Citations

Citations to this article as recorded by  
  • A >50% Intraoperative Parathyroid Hormone Level Decrease Into Normal Reference Range Predicts Complete Excision of Malignancy in Patients With Parathyroid Carcinoma
    Valerie L. Armstrong, Tanaz M. Vaghaiwalla, Cima Saghira, Cheng-Bang Chen, Yujie Wang, Johan Anantharaj, Mehmet Ackin, John I. Lew
    Journal of Surgical Research.2024; 300: 567.     CrossRef
  • Intraoperative parathyroid hormone monitoring in parathyroidectomy for hyperparathyroidism: a protocol for a network meta-analysis of diagnostic test accuracy
    Phillip Staibano, Kevin Um, Sheila Yu, Mohit Bhandari, Michael K. Gupta, Michael Au, JEM (Ted) Young, Han Zhang
    Frontiers in Surgery.2024;[Epub]     CrossRef
  • Primary Hyperparathyroidism
    Saba Kurtom, Sally E. Carty
    Surgical Clinics of North America.2024; 104(4): 799.     CrossRef
  • Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa
    Kamal Govind, Imran M. Paruk, Ayesha A. Motala
    BMC Endocrine Disorders.2024;[Epub]     CrossRef
  • The significance of determining the Intraoperative level of parathormone during surgical treatment of hyperparathyroidism
    Stefan Janičić, Kristina Stepanović, Mia Manojlović, Dean Bjelajac, Slađana Pejaković, Milan Mirković, Dragana Tomić-Naglić, Ivana Bajkin, Tijana Ičin
    Hospital Pharmacology - International Multidisciplinary Journal.2024; 11(2): 1462.     CrossRef
  • Revolutionizing parathyroid surgery: the impact of ultrafast intraoperative parathyroid hormone monitoring on patient outcomes
    Ayush Anand, Ghomsi M.C. Nathalie, Obianuju Iheomamere Muoghallu, Prakasini Satapathy, Rakesh Kumar Sharma, Mahalaqua Nazli Khatib, Shilpa Gaidhane, Quazi Syed Zahiruddin, Sarvesh Rustagi, Kelechi Michael Azode
    International Journal of Surgery Open.2024; 62(4): 534.     CrossRef
  • A new approach for perioperative parathyroid hormone (PTH) measurement to establish cure in patients with primary hyperparathyroidism
    Beatrice Sperotto, Natalie Meurer, Anke Meyer, Parviz Ahmad-Nejad, Norbert Bösing, Nadine Lange, Cornelia Dotzenrath, Pier Francesco Alesina
    Langenbeck's Archives of Surgery.2024;[Epub]     CrossRef
  • Parathyroidectomy for primary hyperparathyroidism: A retrospective analysis of localization, surgical characteristics, and treatment outcomes
    Dongbin Ahn, Ji Hye Kwak, Gil Joon Lee, Jin Ho Sohn
    Asian Journal of Surgery.2023; 46(2): 788.     CrossRef
  • Magnitude of parathyroid hormone elevation in primary hyperparathyroidism: Does time of day matter?
    C. Corbin Frye, Janessa Sullivan, Sai Anusha Sanka, Jingxia Liu, L. Michael Brunt, William Gillanders, Taylor C. Brown, T.K. Pandian
    Surgery.2023; 173(3): 659.     CrossRef
  • Analysis of intraoperative laboratory measurements and imaging techniques such as Tc-99 m-MIBI SPECT/CT, 18F-fluorocholine PET/CT and ultrasound in patients operated with prediagnosis of parathyroid adenoma
    Nurullah Bilen, Mehmet Avni Gokalp, Latif Yilmaz, Alper Aytekin, Ilyas Baskonus
    Irish Journal of Medical Science (1971 -).2023; 192(4): 1695.     CrossRef
  • Intraoperative Parathyroid Hormone Monitoring Is of Limited Usefulness in Guiding Autotransplantation in Reoperative or Subtotal Parathyroidectomy for Primary Hyperparathyroidism
    Bradley A. Richards, Robert A. Vierkant, Benzon M. Dy, Trenton R. Foster, Travis J. McKenzie, Melanie L. Lyden
    The American Surgeon™.2023; 89(12): 5421.     CrossRef
  • Does 18F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?
    Alessio Imperiale, Jacob Bani, Gianluca Bottoni, Adrien Latgé, Céline Heimburger, Ugo Catrambone, Michel Vix, Giorgio Treglia, Arnoldo Piccardo
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Intraoperative Identification of Thyroid and Parathyroid Tissues During Human Endocrine Surgery Using the MasSpec Pen
    Rachel J. DeHoog, Mary E. King, Michael F. Keating, Jialing Zhang, Marta Sans, Clara L. Feider, Kyana Y. Garza, Alena Bensussan, Anna Krieger, John Q. Lin, Sunil Badal, Elizabeth Alore, Christopher Pirko, Kirtan Brahmbhatt, Wendong Yu, Raymon Grogan, Livi
    JAMA Surgery.2023; 158(10): 1050.     CrossRef
  • A Rare Case of Recurrent Parathyroid Adenomas After Initial Parathyroidectomy
    Grant N Schalet, Luke Vincent, Carl Eguez, Gerardo Diaz, Mark S Shachner
    Cureus.2023;[Epub]     CrossRef
  • Surgical treatment of tertiary hyperparathyroidism: does one fit for all?
    Claudio Casella, Claudio Guarneri, Manuela Campanile, Xavier Adhoute, Pier Paolo Gelera, Riccardo Morandi
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Variation in parathyroid adenoma size in patients with sporadic, primary hyperparathyroidism: small gland size does not preclude single gland disease
    Sophie Dream, Tina W. F. Yen, Kara Doffek, Douglas B. Evans, Tracy S. Wang
    Langenbeck's Archives of Surgery.2022; 407(5): 2067.     CrossRef
  • Role and Recent Trend of Intraoperative Parathyroid Hormone Monitoring During Parathyroidectomy in Patients With Primary Hyperparathyroidism
    Dongbin Ahn, Ji Hye Kwak
    Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2022; 65(5): 253.     CrossRef
  • Parathyroid Adenoma: Rare Cause of Acute Recurrent Pancreatitis
    Shikha Mahajan, Alka Kumar, Vivek Aggarwal, Vikas Jain, Vipul Baweja, Ajay Ajmani, Diplomate CBNC, Fellow EBNM LNU
    Annals of Pediatric Gastroenterology and Hepatology.2022; 2(3-4): 9.     CrossRef
  • Long-term outcome of surgical techniques for sporadic primary hyperparathyroidism in a tertiary referral center in Belgium
    Klaas Van Den Heede, Amélie Bonheure, Nele Brusselaers, Sam Van Slycke
    Langenbeck's Archives of Surgery.2022; 407(7): 3045.     CrossRef
  • Contribution of intraoperative parathyroid hormone monitoring to the surgical success in minimal invasive parathyroidectomy
    Ismail Ethem Akgün, Mehmet Taner Ünlü, Nurcihan Aygun, Mehmet Kostek, Mehmet Uludag
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Surgery for primary hyperparathyroidism
    Murilo Catafesta das Neves, Rodrigo Oliveira Santos, Monique Nakayama Ohe
    Archives of Endocrinology and Metabolism.2022; 66(5): 678.     CrossRef
  • Використання інтраопераційного моніторингу рівня паратиреоїдного гормону в мінімально інвазивній хірургії щитоподібної та паращитоподібних залоз
    S.V. Chernyshov, A.V. Tymkiv, A.V. Vovkanych, I.I. Komisarenko
    Endokrynologia.2022; 27(4): 311.     CrossRef
  • Diagnostic Values of Intraoperative (1-84) Parathyroid Hormone Levels are Superior to Intact Parathyroid Hormone for Successful Parathyroidectomy in Patients With Chronic Kidney Disease
    Fangyan Xu, Yaoyu Huang, Ming Zeng, Lina Zhang, Wenkai Ren, Hanyang Qian, Ying Cui, Guang Yang, Wenbin Zhou, Shui Wang, Hui Huang, Huimin Chen, Yujie Xiao, Xueyan Gao, Zhanhui Gao, Jing Wang, Cuiping Liu, Jing Zhang, Baiqiao Zhao, Anning Bian, Fan Li, Hui
    Endocrine Practice.2021; 27(11): 1065.     CrossRef
  • Delayed Calcium Normalization after Successful Parathyroidectomy in Primary Hyperparathyroidism
    Iván Emilio de la Cruz Rodríguez, Elsy Sarahí García Montesinos, María Fernanda Rodríguez-Delgado, Guadalupe Vargas Ortega, Lourdes Balcázar Hernández, Victoria Mendoza Zubieta, Victor Hernández Avendaño, Baldomero González Virla, Micha�l R. Laurent
    Case Reports in Endocrinology.2021; 2021: 1.     CrossRef
  • Parathyroid Surgery
    Aditya S. Shirali, Uriel Clemente-Gutierrez, Nancy D. Perrier
    Neuroimaging Clinics of North America.2021; 31(3): 397.     CrossRef
  • Focused parathyroidectomy without intraoperative parathyroid hormone measurement in primary hyperparathyroidism: Still a valid approach?
    Shelby Holt
    Surgery.2021; 170(6): 1860.     CrossRef
  • Response to the Comment on “Risk Factors of Redo Surgery After Unilateral Focused Parathyroidectomy – Conclusions From a Comprehensive Nationwide Database of 13,247 Interventions Over 6 Years”
    Robert Caiazzo, Camille Marciniak, Francois Pattou
    Annals of Surgery.2021; 274(6): e861.     CrossRef
Close layer
Case Reports
A Case of Subsequent Papillary Carcinoma of the Thyroid gland and Hashimoto's Thyroiditis.
Sang Woong Han, Yong Seon So, Seok Hwan Kim, Ki Hyun Kwon, Tae Hyeung Kim, Jong Soon Kim, Kwang Hoe Kim, Byung Doo Lee
J Korean Endocr Soc. 1996;11(2):214-220.   Published online November 7, 2019
  • 1,247 View
  • 31 Download
AbstractAbstract PDF
The association of thyroid carcinoma and Hashimotos thyroiditis in same thyroid gland is controversial. Incidence of carcinoma who has Hashimotos thyroiditis has been reported from 0.5 to 22.5 per cent by Crile and by Hirabayashi et al. The reason that there are such great diffarences in the reported incidences of carcinoma in Hashimotos disease is the result of the way the material is reported. The carcinomas of the thyroid which occur in association with Hashirnotos thyroiditis are predominently papillary tumors of lower grade malignancy. Thyroid carcinoma need not be feared in patimts with Hashimotos thymiditis, if one examines the ghmd catefully. When patients with Hashimotos disease are treated with thyroxine, there is little or no tendency for Hashimotos disease propess to clinieally detectable carcinoma of the thymid, and the microcarcinoma does not appear. In this case, single thyroid nodule was detected in Hashiimotos disease patient who was treated with thyroxine. There was no significant volume change of thyroid nodule despite of TSH suppression therapy during six months. Therefore we perforrned FNABC twice, the results were highly suspicious thyroid malignancy and subtotoal thyroidectomy was performed. The final pathologic result was microscopic papillary carcinoma with background Hashlmotos thyroiditis. In conclusion, we experienced a case of subsequent microscopic papillary carcinoma of the thyroid in patient with Hashimotos thyroiditis who was TSH suppression therapy with thyroxine.
Close layer
Two Cases of Tubereuloeis of the Thyroid Gland with Euthyroidism.
Jae Bok Lee, Seok Man Son, Kyoung Seog Lee, Yeong Tae Jeong, In Joo Kim, Yong Ki Kim
J Korean Endocr Soc. 1994;9(4):380-384.   Published online November 6, 2019
  • 1,398 View
  • 23 Download
AbstractAbstract PDF
Tuberculosis of the thyroid gland is extremely rare with few cases reported in recent years. Tuberculosis may involve the thyroid gland in two main forms. The more common of theses is miliary spread to the thyroid as part of generalized dissemination and less commonly focal or caseous tuberculosis of the thyroid may occur, presenting as a nodule, as a thyroiditis, as a abscess, or as carcinoma like.We experienced two cases of tuberculosis of the thyroid gland presenting with palpable thyroid nodule in 26 year-old female and 65 year-old female patients. They have been clinically and biochemically euthyroid and their thyroid scans demonstrated a cold nodule at right thyroid gland. We found no evidence of tuberculosis elsewhere. The goiter was removed surgically and confirmed to be tuberculosis. They were medicated antituberculous agents after operation and followed up regulary out patient department.We report the cases of two patients with tuberculosis involving thyroid with reviews of literature.
Close layer
Original Articles
Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015
Won Gu Kim, Won Bae Kim, Gyeongji Woo, Hyejin Kim, Yumi Cho, Tae Yong Kim, Sun Wook Kim, Myung-Hee Shin, Jin Woo Park, Hai-Lin Park, Kyungwon Oh, Jae Hoon Chung
Endocrinol Metab. 2017;32(1):106-114.   Published online January 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.106
Correction in: Endocrinol Metab 2023;38(3):357
  • 8,948 View
  • 212 Download
  • 74 Web of Science
  • 81 Crossref
AbstractAbstract PDFPubReader   
Background

No nationwide epidemiological study evaluating the prevalence of subclinical and overt forms of hypothyroidism and hyperthyroidism has yet been conducted in Korea. This study aimed to evaluate the reference range of serum thyroid stimulating hormone (TSH) and the national prevalence of thyroid dysfunctions in Korea.

Methods

Nation-wide cross-sectional data were analyzed from a representative sample of the civilian, non-institutionalized Korean population (n=6,564) who underwent blood testing for thyroid function and anti-thyroid peroxidase antibody (TPOAb) as part of the Korea National Health and Nutrition Examination Survey VI (2013 to 2015).

Results

The reference interval of serum TSH in the Korean reference population was 0.62 to 6.68 mIU/L. Based on this reference interval, the prevalence of overt and subclinical hypothyroidism was 0.73% (males 0.40%, females 1.10%) and 3.10% (males 2.26%, females 4.04%), respectively. The prevalence of hypothyroidism increased with age until the age group between 50 to 59 years. Positive TPOAb were found in 7.30% of subjects (males 4.33%, females 10.62%). The prevalence of overt and subclinical hypothyroidism TPOAb-positive subjects was 5.16% and 10.88%, respectively. The prevalence of overt and subclinical hyperthyroidism was 0.54% (males 0.30%, females 0.81%) and 2.98% (males 2.43%, females, 3.59%), respectively.

Conclusion

The Serum TSH reference levels in the Korean population were higher than the corresponding levels in Western countries. Differences were found in the prevalence of hypothyroidism and hyperthyroidism according to age, sex, and TPOAb positivity. This study provides important baseline information for understanding patterns of thyroid dysfunction and diseases in Korea.

Citations

Citations to this article as recorded by  
  • Deciphering the roles of triiodothyronine (T3) and thyroid-stimulating hormone (TSH) on cardiac electrical remodeling in clinical and experimental hypothyroidism
    Oscar Casis, Leire Echeazarra, Beatriz Sáenz-Díez, Mónica Gallego
    Journal of Physiology and Biochemistry.2024; 80(1): 1.     CrossRef
  • The Impact of Physical Activity on Thyroid Health: Insights From Representative Data in Korea
    Jeongmin Lee, Han-Sang Baek, Kwanhoon Jo, Min-Hee Kim, Jung Min Lee, Sang Ah Chang, Dong-Jun Lim
    The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
  • Associations between short-term exposure to air pollution and thyroid function in a representative sample of the Korean population
    Kyoung-Nam Kim, SoHyun Park, Junseo Choi, Il-Ung Hwang
    Environmental Research.2024; 252: 119018.     CrossRef
  • Association between ambient temperature and thyroid-stimulating hormone and free thyroxine levels in Korean euthyroid adults
    Jisun Sung, Jong-Hun Kim
    Environmental Research.2024; 262: 119918.     CrossRef
  • Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study
    Hye Jeong Kim, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo
    BMC Nephrology.2023;[Epub]     CrossRef
  • Association between iodine intake and metabolic syndrome in euthyroid adult in an iodine-replete area: a nationwide population-based study
    Hye Jeong Kim, Suyeon Park, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo
    Endocrine Journal.2023; 70(4): 393.     CrossRef
  • 2023 Korean Thyroid Association Management Guidelines for Patients with Subclinical Hypothyroidism
    Hyun Kyung Chung, Eu Jeong Ku, Won Sang Yoo, Yea Eun Kang, Kyeong Jin Kim, Bo Hyun Kim, Tae-Yong Kim, Young Joo Park, Chang Ho Ahn, Jee Hee Yoon, Eun Kyung Lee, Jong Min Lee, Eui Dal Jung, Jae Hoon Chung, Yun Jae Chung, Won Bae Kim, Ka Hee Yi, Ho-Cheol Ka
    International Journal of Thyroidology.2023; 16(1): 32.     CrossRef
  • The Current Status of Hyperthyroidism in Korea
    Hyemi Kwon
    Endocrinology and Metabolism.2023; 38(4): 392.     CrossRef
  • Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines
    Eu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2023; 38(4): 381.     CrossRef
  • Association between shift work and the risk of hypothyroidism in adult male workers in Korea: a cohort study
    Seonghyeon Kwon, Yesung Lee, Eunhye Seo, Daehoon Kim, Jaehong Lee, Youshik Jeong, Jihoon Kim, Jinsook Jeong, Woncheol Lee
    Annals of Occupational and Environmental Medicine.2023;[Epub]     CrossRef
  • Depressão e hipotireoidismo: Uma revisão sistemática
    Eduarda Silva Souza, Rosangela Soares Chriguer, Maria Cristina Mazzaia
    Revista Portuguesa de Investigação Comportamental e Social.2023;[Epub]     CrossRef
  • Comparison of Thyroid-Stimulating Hormone Results from Eight Different Reagents and Assay-Specific Korean Reference Interval for Subclinical Hypothyroidism Treatment
    Won Sang Yoo, Sollip Kim, Young Joo Park, Sang Hoon Song, Kyunghoon Lee, Eun Kyung Lee, Jehoon Lee, Ho-Young Lee, Yun Jae Chung, Hyun Kyung Chung, Jin Chul Paeng, Minje Han, Ho-Cheol Kang
    International Journal of Thyroidology.2023; 16(2): 166.     CrossRef
  • Comparison of Five Different Criteria for Diagnosis of Subclinical Hypothyroidism in a Large-Scale Chinese Population
    Yan-song Zheng, Sheng-yong Dong, Yan Gong, Jia-hong Wang, Fei Wang, Qiang Zeng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Association of thyroid autoimmunity with nonalcoholic fatty liver disease in euthyroid middle‐aged subjects: A population‐based study
    Hye Jeong Kim, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo
    Journal of Gastroenterology and Hepatology.2022; 37(8): 1617.     CrossRef
  • Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis
    Wook Yi, Bo Hyun Kim, Mijin Kim, Jinmi Kim, Myungsoo Im, Soree Ryang, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim
    Thyroid.2022; 32(7): 764.     CrossRef
  • Association of free thyroxine with obstructive lung pattern in euthyroid middle-aged subjects: A population-based study
    Hye Jeong Kim, Sang Joon Park, Hyeong Kyu Park, Dong Won Byun, Kyoil Suh, Myung Hi Yoo, Dong Keon Yon
    PLOS ONE.2022; 17(7): e0270126.     CrossRef
  • Long working hours and the risk of hypothyroidism in healthy Korean workers: a cohort study
    Yesung Lee, Woncheol Lee, Hyoung-Ryoul Kim
    Epidemiology and Health.2022; 44: e2022104.     CrossRef
  • Association of breastfeeding with thyroid function and autoimmunity in postmenopausal women
    Sung-Woo Kim, Ji-Hyun Lee, Ho-Sang Shon, Eonju Jeon, Tae-Yong Kim
    Endocrine.2021; 71(1): 130.     CrossRef
  • Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China
    B. Ren, S. Wan, L. Liu, M. Qu, H. Wu, H. Shen
    Journal of Endocrinological Investigation.2021; 44(5): 1001.     CrossRef
  • Low Thyroid-stimulating Hormone Levels Are Associated With Annoying Tinnitus in Adult Women: Korea National Health and Nutrition Examination Surveys
    So Young Kim, Chanyang Min, Hyung-Jong Kim, Hyo Geun Choi
    Otology & Neurotology.2021; 42(4): e408.     CrossRef
  • Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study
    Seo Young Sohn, Gi Hyeon Seo, Jae Hoon Chung
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Decreased Expression of Ileal Thyroid Hormone Transporters in a Hypothyroid Patient: A Case Report
    Chae Won Chung, Eun Young Mo, Gyung Seo Jung, Yoo Hyung Kim, Sun Wook Cho, Do Joon Park, Jeong Mo Bae, Young Joo Park
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions
    Kyungwon Oh, Yoonjung Kim, Sanghui Kweon, Soyeon Kim, Sungha Yun, Suyeon Park, Yeon-Kyeng Lee, Youngtaek Kim, Ok Park, Eun Kyeong Jeong
    Epidemiology and Health.2021; 43: e2021025.     CrossRef
  • Association between triglyceride-glucose index and thyroid function in euthyroid adults: The Korea National Health and Nutritional Examination Survey 2015
    Wonsuk Choi, Ji Yong Park, A. Ram Hong, Jee Hee Yoon, Hee Kyung Kim, Ho-Cheol Kang, Sun Young Lee
    PLOS ONE.2021; 16(7): e0254630.     CrossRef
  • Association between Subclinical Hypothyroidism and Incident Hypertension in Women: A Systematic Review and Meta-Analysis
    Jean Kim, Narut Prasitlumkum, Sandeep Randhawa, Dipanjan Banerjee
    Journal of Clinical Medicine.2021; 10(15): 3318.     CrossRef
  • Sex Difference in the Association between Sleep Duration and Thyroid Disease among South Korean Adults
    Jeong Hyun Ahn, Jin Young Nam, Soojin Park
    Journal of Health Informatics and Statistics.2021; 46(3): 337.     CrossRef
  • The Association between the Dietary Inflammatory Index and Thyroid Function in U.S. Adult Males
    Nuozhou Liu, Fang Ma, Ying Feng, Xue Ma
    Nutrients.2021; 13(10): 3330.     CrossRef
  • T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
    Wilmar M. Wiersinga
    Endocrinology and Metabolism.2021; 36(5): 938.     CrossRef
  • Association between thyroid hormones and insulin resistance indices based on the Korean National Health and Nutrition Examination Survey
    Yun Mi Choi, Min Kyung Kim, Mi Kyung Kwak, Dooman Kim, Eun-Gyoung Hong
    Scientific Reports.2021;[Epub]     CrossRef
  • Implication of thyroid function in periodontitis: a nationwide population-based study
    Eyun Song, Min Jeong Park, Jung A. Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
    Scientific Reports.2021;[Epub]     CrossRef
  • Association between thyroid hormone and components of metabolic syndrome in euthyroid Korean adults
    Kyung A. Shin, Eun Jae Kim
    Medicine.2021; 100(51): e28409.     CrossRef
  • Association between Serum Free Thyroxine and Anemia in Euthyroid Adults: A Nationwide Study
    Mijin Kim, Bo Hyun Kim, Hyungi Lee, Min Hee Jang, Jeong Mi Kim, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim
    Endocrinology and Metabolism.2020; 35(1): 106.     CrossRef
  • Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
    Won Bae Kim, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong
    Endocrinology and Metabolism.2020; 35(1): 14.     CrossRef
  • Long Work Hours Are Associated with Hypothyroidism: A Cross-Sectional Study with Population-Representative Data
    Young Ki Lee, Dong-eun Lee, Yul Hwangbo, You Jin Lee, Hyeon Chang Kim, Eun Kyung Lee
    Thyroid.2020; 30(10): 1432.     CrossRef
  • Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population
    K. Lee, S. Lim, H. Park, H.Y. Woo, Y. Chang, E. Sung, H.S. Jung, K.E. Yun, C.W. Kim, S. Ryu, M.J. Kwon
    Osteoporosis International.2020; 31(3): 547.     CrossRef
  • Update on Thyroid Hormone Levels and Thyroid Dysfunction in the Korean Population Based on Data from the Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2020; 35(1): 7.     CrossRef
  • Assessment of the relationship between knee ultrasound and clinical symptoms in patients with thyroid dysfunction
    Bo Young Kim, Sung-Soo Kim, Hyeong Kyu Park, Hyun-Sook Kim
    Journal of International Medical Research.2020; 48(1): 030006051989770.     CrossRef
  • Association between urinary sodium levels and iodine status in Korea
    Jonghwa Ahn, Jang Ho Lee, Jiwoo Lee, Ji Yeon Baek, Eyun Song, Hye-Seon Oh, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Won Gu Kim
    The Korean Journal of Internal Medicine.2020; 35(2): 392.     CrossRef
  • Association of Thyroid Status with Health-Related Quality of Life in Korean Older Adults
    Minjung Han, Seulggie Choi, Sarang Kim, Ahryoung Ko, Joung Sik Son, Sang Min Park
    Korean Journal of Family Medicine.2020; 41(1): 38.     CrossRef
  • High neutrophil-to-lymphocyte ratio is associated with relapse in Graves’ disease after antithyroid drug therapy
    Mijin Kim, Bo Hyun Kim, Min Hee Jang, Jeong Mi Kim, Eun Heui Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim
    Endocrine.2020; 67(2): 406.     CrossRef
  • Sex differences in subclinical hypothyroidism and associations with metabolic risk factors: a health examination-based study in mainland China
    Li Jiang, Jinman Du, Weizhu Wu, Jianjiang Fang, Jufang Wang, Jinhua Ding
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Association between Serum Free Thyroxine and Anemia in Euthyroid Adults: A Nationwide Study (Endocrinol Metab 2020;35:106-14, Mijin Kim et al.)
    Mijin Kim, Bo Hyun Kim
    Endocrinology and Metabolism.2020; 35(3): 669.     CrossRef
  • Urinary Iodine Concentration and Thyroid Peroxidase Antibodies in the Korean Population Using Korea National Health and Nutrition Examination Survey VI
    Myung-Chul Chang
    International Journal of Thyroidology.2020; 13(2): 155.     CrossRef
  • Recent Issues Related to Thyroid Disease in Pregnancy
    Jae Hoon Chung
    International Journal of Thyroidology.2020; 13(2): 85.     CrossRef
  • Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)
    Hanneke J. C. M. Wouters, Sandra N. Slagter, Anneke C. Muller Kobold, Melanie M. van der Klauw, Bruce H. R. Wolffenbuttel, Silvia Naitza
    PLOS ONE.2020; 15(11): e0242795.     CrossRef
  • Hipertiroidi Hastalarında Tedavi Öncesi ve Sonrası Trombosit/Lenfosit ve Nötrofil/Lenfosit Oranlarının Değerlendirilmesi
    Çiğdem CİNDOĞLU, Mehmet GÜLER, Mehmet Ali EREN, Tevfik SABUNCU
    Harran Üniversitesi Tıp Fakültesi Dergisi.2020; 17(1): 104.     CrossRef
  • Association between Sleep Duration and Subclinical Thyroid Dysfunction Based on Nationally Representative Data
    Woojun Kim, Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Min-Hee Kim
    Journal of Clinical Medicine.2019; 8(11): 2010.     CrossRef
  • High Normal Range of Free Thyroxine is Associated with Decreased Triglycerides and with Increased High-Density Lipoprotein Cholesterol Based on Population Representative Data
    Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Min-Hee Kim
    Journal of Clinical Medicine.2019; 8(6): 758.     CrossRef
  • Association High-Iodine-Containing Seaweed Soup Consumption after Birth and Subclinical Hypothyroidism in Korean Women: Korea National Health and Nutrition Examination Survey IV (2013–2015)
    Hyunsam Kim, Ha Ni Lee, Jeonghoon Ha
    International Journal of Thyroidology.2019; 12(2): 105.     CrossRef
  • Reference Range and Sociodemographic Characteristics of TSH among Reproductive Age Women in Rural China
    Qiang Su, Shikun Zhang, Mei Hu, Qiaomei Wang, Na Liu, Haiping Shen, Yiping Zhang, Man Zhang
    Biological Trace Element Research.2019; 189(2): 336.     CrossRef
  • Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
    Daham Kim, Yongin Cho, Cheol Ryong Ku, Hyein Jung, Ju Hyung Moon, Eui Hyun Kim, Dong Yeob Shin, Sun Ho Kim, Eun Jig Lee
    Journal of Clinical Medicine.2019; 8(8): 1142.     CrossRef
  • Thyroid Dysfunction in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: A Monocentric Retrospective Study
    JAE YEON KIM, YONG-BEOM PARK, SANG-WON LEE
    The Journal of Rheumatology.2019; 46(9): 1248.     CrossRef
  • Thyroid dysfunction in patients with suspected or documented supraventricular tachyarrhythmia
    Hye Bin Gwag, Ji Eun Jun, Youngjun Park, Seong Soo Lee, Seung-Jung Park, June Soo Kim, Kyoung-Min Park, Young Keun On
    International Journal of Arrhythmia.2019;[Epub]     CrossRef
  • Association between Iodine Nutrition Status and Thyroid Disease-Related Hormone in Korean Adults: Korean National Health and Nutrition Examination Survey VI (2013–2015)
    Sohye Kim, Yong Seok Kwon, Ju Young Kim, Kyung Hee Hong, Yoo Kyoung Park
    Nutrients.2019; 11(11): 2757.     CrossRef
  • Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus
    T. I. de Vries, L. J. Kappelle, Y. van der Graaf, H. W. de Valk, G. J. de Borst, H. M. Nathoe, F. L. J. Visseren, Jan Westerink
    Acta Diabetologica.2019; 56(4): 431.     CrossRef
  • The Association between Low Vitamin D Status and Autoimmune Thyroid Disease in Korean Premenopausal Women: The 6th Korea National Health and Nutrition Examination Survey, 2013–2014
    Choon-Young Kim, Yeon Ji Lee, Ji-Ho Choi, Soo Yeon Lee, Hye Young Lee, Da Hye Jeong, Yeon Jun Choi
    Korean Journal of Family Medicine.2019; 40(5): 323.     CrossRef
  • Associations between urine iodine and allergic diseases in the Korean National Health and Nutrition Examination Survey 2013–2015: A STROBE-compliant article
    Young Bok Lee, Ji hyun Lee, Min Ji Kang, Dong Soo Yu, Kyung Do Han, Yong Gyu Park
    Phytomedicine.2019; 62: 152937.     CrossRef
  • The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults
    Jeong Mi Kim, Bo Hyun Kim, Hyungi Lee, Eun Heui Kim, Mijin Kim, Jong Ho Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim, Yong Ki Kim
    Diabetes & Metabolism Journal.2019; 43(6): 867.     CrossRef
  • Sex-Dependent Association between Weight Change and Thyroid Dysfunction: Population-Level Analysis Using the Korean National Health and Nutrition Examination Survey
    Eyun Song, Jonghwa Ahn, Hye-Seon Oh, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Tae Yong Kim
    European Thyroid Journal.2019; 8(4): 202.     CrossRef
  • Subclinical Hypothyroidism: is it Really Subclinical with Aging?
    Robin Gourmelon, Sandrine Donadio-Andréi, Karim Chikh, Muriel Rabilloud, Elisabetta Kuczewski, Anne-Sophie Gauchez, Anne Charrié, Pierre-Yves Brard, Raphaëlle Andréani, Jean-Cyril Bourre, Christine Waterlot, Domitille Guédel, Anne Mayer, Emmanuel Disse, C
    Aging and disease.2019; 10(3): 520.     CrossRef
  • Serum thyroid‐stimulating hormone levels and smoking status: Data from the Korean National Health and Nutrition Examination Survey VI
    Suyeon Park, Won Gu Kim, Min Ji Jeon, Mijin Kim, Hye‐Seon Oh, Minkyu Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Clinical Endocrinology.2018; 88(6): 969.     CrossRef
  • Sex-specific genetic influence on thyroid-stimulating hormone and free thyroxine levels, and interactions between measurements: KNHANES 2013–2015
    Young Ki Lee, Dong Yeob Shin, Hyejung Shin, Eun Jig Lee, Silvia Naitza
    PLOS ONE.2018; 13(11): e0207446.     CrossRef
  • Ten Years of the Korean Thyroid Association: Achievement and Future
    Young Joo Park, Young Shin Song, Ka Hee Yi
    International Journal of Thyroidology.2018; 11(1): 1.     CrossRef
  • Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAFV600E mutation
    Young Ki Lee, Kyeong Hye Park, Se Hee Park, Kwang Joon Kim, Dong Yeob Shin, Kee Hyun Nam, Woong Youn Chung, Eun Jig Lee
    Head & Neck.2018; 40(10): 2271.     CrossRef
  • Prevalence and Annual Incidence of Thyroid Disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study
    Hyemi Kwon, Jin-hyung Jung, Kyung-Do Han, Yong-Gyu Park, Jung-Hwan Cho, Da Young Lee, Ji Min Han, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2018; 33(2): 260.     CrossRef
  • Evaluation of Thyroid Hormone Levels and Urinary Iodine Concentrations in Koreans Based on the Data from Korea National Health and Nutrition Examination Survey VI (2013 to 2015)
    Jae Hoon Chung
    Endocrinology and Metabolism.2018; 33(2): 160.     CrossRef
  • Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country
    Carmen Castillo, Nicole Lustig, Paula Margozzini, Andrea Gomez, María Paulina Rojas, Santiago Muzzo, Lorena Mosso
    Endocrinology and Metabolism.2018; 33(4): 466.     CrossRef
  • Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015
    Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Bong-Yun Cha, Min-Hee Kim
    Scientific Reports.2018;[Epub]     CrossRef
  • Sex differences in risk factors for subclinical hypothyroidism
    Jeonghoon Ha, Jeongmin Lee, Kwanhoon Jo, Dong-Jun Lim, Moo Il Kang, Bong Yun Cha, Min-Hee Kim
    Endocrine Connections.2018; 7(4): 511.     CrossRef
  • Associations of Urinary Cotinine-Verified Active and Passive Smoking with Thyroid Function: Analysis of Population-Based Nationally Representative Data
    Jihun Kang, Eunhee Kong, Jongsoon Choi
    Thyroid.2018; 28(5): 583.     CrossRef
  • Establishment of Korean Thyroid Association-10 Years of Development in Internal Medicine
    Jae Hoon Chung
    International Journal of Thyroidology.2018; 11(1): 7.     CrossRef
  • Association between subclinical thyroid dysfunction and depressive symptoms in the Korean adult population: The 2014 Korea National Health and Nutrition Examination Survey
    Jae Won Hong, Jung Hyun Noh, Dong-Jun Kim, Osama Ali Abulseoud
    PLOS ONE.2018; 13(8): e0202258.     CrossRef
  • Association Between Thyroid Dysfunction and Lipid Profiles Differs According to Age and Sex: Results from the Korean National Health and Nutrition Examination Survey
    Hye-Seon Oh, Hyemi Kwon, Jonghwa Ahn, Eyun Song, Suyeon Park, Mijin Kim, Minkyu Han, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Eun-Jung Rhee, Tae Yong Kim
    Thyroid.2018; 28(7): 849.     CrossRef
  • The Relationship between Subclinical Thyroid Disease and Cardiovascular Disease Risk Score in Koreans
    Hee Joong Lim, Seong Hee Ahn, Seongbin Hong, Young Ju Suh
    Journal of Korean Medical Science.2017; 32(10): 1626.     CrossRef
  • Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data
    Yun Mi Choi, Won Gu Kim, Hyemi Kwon, Min Ji Jeon, Minkyu Han, Tae Yong Kim, Young Kee Shong, Sang Mo Hong, Eun‐Gyoung Hong, Won Bae Kim
    Cancer.2017; 123(24): 4808.     CrossRef
  • Response: Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (Endocrinol Metab 2017;32:106-14, Won Gu Kim et al.)
    Won Gu Kim, Jae Hoon Chung
    Endocrinology and Metabolism.2017; 32(2): 304.     CrossRef
  • Excessive Iodine Intake and Thyrotropin Reference Interval: Data from the Korean National Health and Nutrition Examination Survey
    Min Ji Jeon, Won Gu Kim, Hyemi Kwon, Mijin Kim, Suyeon Park, Hye-Seon Oh, Minkyu Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(7): 967.     CrossRef
  • Subclinical thyroid dysfunction and risk of carotid atherosclerosis
    Hosu Kim, Tae Hyuk Kim, Hye In Kim, So Young Park, Young Nam Kim, Seonwoo Kim, Min-Ji Kim, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Yong-Ki Min, Jae Hoon Chung, Mira Kang, Sun Wook Kim, Tatsuo Shimosawa
    PLOS ONE.2017; 12(7): e0182090.     CrossRef
  • Letter: Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (Endocrinol Metab 2017;32:106-14, Won Gu Kim et al.)
    Young Ki Lee, Dong Yeob Shin
    Endocrinology and Metabolism.2017; 32(2): 302.     CrossRef
  • Vitamin D deficiency affects thyroid autoimmunity and dysfunction in iodine-replete area: Korea national health and nutrition examination survey
    Mijin Kim, Eyun Song, Hye-Seon Oh, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Tae Yong Kim
    Endocrine.2017; 58(2): 332.     CrossRef
  • Viral Hepatitis in South Korea
    Stella C Pak, Yaseen Alastal, Zubair Khan, Umar Darr
    Euroasian Journal of Hepato-Gastroenterology.2017; 7(2): 163.     CrossRef
Close layer
Thyroid
Risk of Malignancy in Thyroid Incidentalomas Identified by Fluorodeoxyglucose-Positron Emission Tomography
A Reum Chun, Hye Min Jo, Seoung Ho Lee, Hong Woo Chun, Jung Mi Park, Kyu Jin Kim, Chan Hee Jung, Ji Oh Mok, Sung Koo Kang, Chul Hee Kim, Bo Yeon Kim
Endocrinol Metab. 2015;30(1):71-77.   Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.71
  • 4,674 View
  • 49 Download
  • 28 Web of Science
  • 26 Crossref
AbstractAbstract PDFPubReader   
Background

Thyroid incidentalomas detected by 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) have been reported in 1% to 4% of the population, with a risk of malignancy of 27.8% to 74%. We performed a retrospective review of FDG-avid thyroid incidentalomas in cancer screening subjects and patients with nonthyroid cancer. The risk of malignancy in thyroid incidentaloma and its association with the maximal standardized uptake value (SUVmax) in 18F-FDG PET/CT were evaluated to define the predictor variables in assessing risk of malignancy.

Methods

A total of 2,584 subjects underwent 18F-FDG PET/CT for metastatic evaluation or cancer screening from January 2005 to January 2010. Among them, 36 subjects with FDG-avid thyroid incidentalomas underwent further diagnostic evaluation (thyroid ultrasonography-guided fine needle aspiration cytology [FNAC] or surgical resection). We retrospectively reviewed the database of these subjects.

Results

Of the 2,584 subjects who underwent 18F-FDG PET/CT (319 for cancer screening and 2,265 for metastatic evaluation), 52 (2.0%) were identified as having FDG-avid thyroid incidentaloma and cytologic diagnosis was obtained by FNAC in 36 subjects. Of the subjects, 15 were proven to have malignant disease: 13 by FNAC and two by surgical resection. The positive predictive value of malignancy in FDG-avid thyroid incidentaloma was 41.7%. Median SUVmax was higher in malignancy than in benign lesions (4.7 [interquartile range (IQR), 3.4 to 6.0] vs. 2.8 [IQR, 2.6 to 4.0], P=0.001).

Conclusion

Thyroid incidentalomas found on 18F-FDG PET/CT have a high risk of malignancy, with a positive predictive value of 41.7%. FDG-avid thyroid incidentalomas with higher SUVmax tended to be malignant.

Citations

Citations to this article as recorded by  
  • Incidental 68Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Kyla Wright, Jason C. Fisher, Gary D. Rothberger, Jason D. Prescott, John D. Allendorf, Kepal Patel, Insoo Suh
    Surgery.2024; 175(1): 228.     CrossRef
  • Prediction of Malignant Thyroid Nodules Using 18F-FDG PET/CT–Based Radiomics Features in Thyroid Incidentalomas
    Woo Seog Ko, Seong-Jang Kim
    Clinical Nuclear Medicine.2023; 48(6): 497.     CrossRef
  • KSNM60 in Nuclear Endocrinology: from the Beginning to the Future
    Chae Moon Hong, Young Jin Jeong, Hae Won Kim, Byeong-Cheol Ahn
    Nuclear Medicine and Molecular Imaging.2022; 56(1): 17.     CrossRef
  • The value of 99mTc-MIBI scan in the detection of malignancy potential of hypermetabolic thyroid incidentalomas of 18F-FDG PET/CT
    G. Tatar, G. Alçın, Ö. Erol Fenercioglu, E. Beyhan, H.Y. Barut, N. Ergül, T.F. Çermik
    Médecine Nucléaire.2022; 46(3): 139.     CrossRef
  • Diagnosis of thyroid nodules
    Erik K Alexander, Edmund S Cibas
    The Lancet Diabetes & Endocrinology.2022; 10(7): 533.     CrossRef
  • PET/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer
    Jasna Mihailovic, Ronan P. Killeen, John A. Duignan
    Seminars in Nuclear Medicine.2021; 51(5): 419.     CrossRef
  • Characteristics of malignant thyroid lesions on [18F] fluorodeoxyglucose (FDG)-Positron emission tomography (PET)/Computed tomography (CT)
    Hatem Nasr, Hussein Farghaly, Abdullah Alqarni, Seham Al-Salem, Mohamed Sayed
    European Journal of Radiology Open.2021; 8: 100373.     CrossRef
  • Focal Thyroid Incidentalomas on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration
    J. F. de Leijer, M. J. H. Metman, A. van der Hoorn, A. H. Brouwers, S. Kruijff, B. M. van Hemel, T. P. Links, H. E. Westerlaan
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Thyroid incidentaloma: next to be neglected or investigated?
    S.I. Rybakov
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(4): 361.     CrossRef
  • Metastatic renal cell carcinoma in the thyroid gland
    Mark M. Cruz, Gregory S. Schmidt, Jeptha T. Johnson, Thanh D. Hoang, Mohamed K. M. Shakir
    Clinical Case Reports.2020; 8(11): 2302.     CrossRef
  • Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience
    AVSAnil Kumar, Gaurav Datta, Harkirat Singh, ParthaBrata Mukherjee, Shashindran Vangal
    World Journal of Nuclear Medicine.2019; 18(3): 273.     CrossRef
  • Risk of Malignancy in FDG‐Avid Thyroid Incidentalomas on PET/CT: A Prospective Study
    Chadi Nimeh Abdel‐Halim, Tine Rosenberg, Kristine Bjørndal, Anders Rørbæk Madsen, John Jakobsen, Helle Døssing, Mette Bay, Anders Thomassen, Anne Lerberg Nielsen, Christian Godballe
    World Journal of Surgery.2019; 43(10): 2454.     CrossRef
  • Is TI-RADS classification and Score Modified Method of thyroid nodules can be effective for evaluation of Thyroid Incidentalomas on FDG PET-CT imaging
    Kara Pelin Ozcan, Koc Zehra Pinar, Balci Yüksel, Arpaci Rabia Bozdogan
    Open Journal of Thyroid Research.2019; 2(1): 005.     CrossRef
  • Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans
    Filiz Eksi Haydardedeoglu, Gulay Simsek Bagir, Nese Torun, Emrah Kocer, Mehmet Reyhan, Melek Eda Ertorer
    Archives of Endocrinology and Metabolism.2018; 62(4): 460.     CrossRef
  • Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification
    F. J. Pena Pardo, A. M. García Vicente, M. Amo-Salas, J. F. López-Fidalgo, J. A. Garrido Robles, J. Á. de Ayala Fernández, P. del Saz Saucedo, M. Muñoz Pasadas, A. Soriano Castrejón
    Clinical and Translational Oncology.2017; 19(1): 111.     CrossRef
  • Unusual Soft Tissue Uptake of F-18 Sodium Fluoride in Three Patients Undergoing F-18 NaF PET/CT Bone Scans for Prostate Cancer
    Andrew S. Hawkins, Brandon A. Howard
    Nuclear Medicine and Molecular Imaging.2017; 51(3): 274.     CrossRef
  • Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond
    Prasanna Santhanam, Lilja B. Solnes, Steven P. Rowe
    Medical Oncology.2017;[Epub]     CrossRef
  • The assessment of incidental thyroid lesions on 18F-fluorodeoxyglucose positron emission tomography/computed tomogrophy: A single centre experience
    Efnan Algin, Aytug Uner, Umit Ozgur Akdemir, Ozge Gumusay, Ozlem Kapucu, Ahmet Ozet
    Journal of Oncological Sciences.2017; 3(2): 57.     CrossRef
  • Cytological evaluation by fine needle aspiration biopsy of incidental focal increased fluorodeoxyglucose uptake in thyroid on positron emission tomography scan
    Yanchun Li, Min Cui, Nami Azar, Dean Nakamoto, Claire W. Michael
    Diagnostic Cytopathology.2017; 45(6): 501.     CrossRef
  • [18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results
    M. Sollini, L. Cozzi, G. Pepe, L. Antunovic, A. Lania, L. Di Tommaso, P. Magnoni, P. A. Erba, M. Kirienko
    European Journal of Hybrid Imaging.2017;[Epub]     CrossRef
  • Management of PET diagnosed thyroid incidentalomas in British Columbia Canada: Critical importance of the PET report
    Jordan Wong, Kaidi Liu, Celia Siu, Steven Jones, Marlise Sovka, Don Wilson, Sam M. Wiseman
    The American Journal of Surgery.2017; 213(5): 950.     CrossRef
  • Incidental hypermetabolic PET positive lesions in thyroid and pituitary glands in a patient with lung cancer: A case of two uncommon findings in a single patient
    Pratima Nayak, Kyaw Soe, Mona Natwa, Taha Sachak, Ming Jin, Norman L. Lehman, Fadi Nabhan
    Journal of Clinical and Translational Endocrinology: Case Reports.2016; 2: 10.     CrossRef
  • The incidence of 18F-FDG PET/CT thyroid incidentalomas andthe prevalence of malignancy: a prospective study
    Mine ŞENCAN EREN, Özhan ÖZDOĞAN, Arzu GEDİK, Mehmet CEYLAN, Merih GÜRAY DURAK, Mustafa SEÇİL, Mehmet Ali KOÇDOR, Abdurrahman ÇÖMLEKÇİ, Hatice DURAK
    TURKISH JOURNAL OF MEDICAL SCIENCES.2016; 46: 840.     CrossRef
  • Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?
    Krzysztof Kaliszewski, Marta Strutyńska-Karpińska, Agnieszka Zubkiewicz-Kucharska, Beata Wojtczak, Paweł Domosławski, Waldemar Balcerzak, Tadeusz Łukieńczuk, Zdzisław Forkasiewicz, Pei-Yi Chu
    PLOS ONE.2016; 11(12): e0168654.     CrossRef
  • The incidence of thyroid cancer in focal hypermetabolic thyroid lesions
    Martin Barrio, Johannes Czernin, Michael W. Yeh, Miguel F. Palma Diaz, Pawan Gupta, Martin Allen-Auerbach, Christiaan Schiepers, Ken Herrmann
    Nuclear Medicine Communications.2016; 37(12): 1290.     CrossRef
  • Incidental Detection of Follicular Thyroid Carcinoma in 68Ga-PSMA PET/CT Imaging
    Sait Sager, Betül Vatankulu, Lebriz Uslu, Kerim Sönmezoglu
    Journal of Nuclear Medicine Technology.2016; 44(3): 199.     CrossRef
Close layer
Case Reports
Langerhans Cell Histiocytosis in the Thyroid and Draining Lymph Nodes: A Case Report.
Dong Hae Chung, Seung Yeon Ha, Hyun Yee Cho, Na Rae Kim, Jung Suk An, Young Don Lee, Sanghui Park
Endocrinol Metab. 2012;27(2):138-141.   Published online June 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.2.138
  • 2,245 View
  • 57 Download
  • 5 Crossref
AbstractAbstract PDF
A 53-year-old woman was presented with several 0.3-0.6 cm-sized nodules within the right lobe of the thyroid. Histologic sections of the thyroid demonstrated multiple papillary microcarcinomas in the background of lymphocytic thyroiditis, with a small focus of Langerhans cell histiocytosis (LCH). Small LCH nodules were also found in the draining cervical lymph nodes. Although the association of LCH with papillary thyroid carcinoma in the thyroid has been reported, their co-existence with LCH in the draining lymph nodes is very rare.

Citations

Citations to this article as recorded by  
  • Thyroid Langerhans cell histiocytosis concurrent with papillary thyroid carcinoma: A case report and literature review
    Bin Mi, Di Wu, Yue Fan, Benjamin Ka Seng Thong, Yudong Chen, Xue Wang, Chaofu Wang
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Adult Langerhans cell histiocytosis of skull in a patient with synchronous papillary thyroid carcinoma and Castleman disease
    In Kyeong Kim, Kyoung Yul Lee
    BMJ Case Reports.2021; 14(1): e239341.     CrossRef
  • Langerhans cell histiocytosis of the thyroid together with papillary thyroid carcinoma
    Hatice Ozisik, Banu Sarer Yurekli, Derya Demir, Yesim Ertan, Ilgın Yildirim Simsir, Murat Ozdemir, Mehmet Erdogan, Sevki Cetinkalp, Gokhan Ozgen, Fusun Saygili
    Hormones.2020; 19(2): 253.     CrossRef
  • BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review
    Mohammad A. Al Hamad, Hassan M. Albisher, Weam R. Al Saeed, Ahmed T. Almumtin, Fatimah M. Allabbad, Mohammed A. Shawarby
    BMC Cancer.2019;[Epub]     CrossRef
  • Adult Multisystem Langerhans Cell Histiocytosis Presenting with Central Diabetes Insipidus Successfully Treated with Chemotherapy
    Jung-Eun Choi, Hae Ri Lee, Jung Hun Ohn, Min Kyong Moon, Juri Park, Seong Jin Lee, Moon-Gi Choi, Hyung Joon Yoo, Jung Han Kim, Eun-Gyoung Hong
    Endocrinology and Metabolism.2014; 29(3): 394.     CrossRef
Close layer
A Case of Solitary Extramedullary Plasmacytoma of the Thyroid Presented as a Thyroid Tumor with Hashimoto's Thyroiditis.
Eunjung Jo, Dong Woo Ha, Jin Hee Choi, Kyung Nam Lee, Jung Seop Eom, Mi Ra Kim, Yun Kyung Jeon, Sang Soo Kim, Bo Hyun Kim, In Joo Kim
Endocrinol Metab. 2012;27(1):77-82.   Published online March 1, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.1.77
  • 66,273 View
  • 27 Download
  • 1 Crossref
AbstractAbstract PDF
Extramedullary plasmacytomas most commonly occur in the nasal cavity, nasopharynx, paranasal sinuses, and larynx. Solitary extramedullary plasmacytoma (SEP) of the thyroid gland is rare. The diagnosis of SEP of the thyroid by cytology is typically difficult before surgery, and the entity is often confused with different cytology findings. We report a case of a 59-year-old man with primary plasmacytoma of the thyroid presented as a rapidly enlarging thyroid gland with Hashimoto's thyroiditis. He had been suffering from anterior neck swelling for 1 month. Several fine-needle aspiration biopsies yielded Hashimoto's thyroiditis. During a follow-up period of 3 years, the size of the thyroid gland increased and a mass lesion in right thyroid gland was detected. A total thyroidectomy was performed based on a diagnosis of a thyroid tumor with Hashimoto's thyroiditis. Permanent pathology identified the mass as an extramedullary plasmacytoma associated with Hashimoto's thyroiditis. Skeletal survey and serum electrophoresis tests were normal, and a bone marrow biopsy yielded no evidence of multiple myeloma. The patient underwent definitive radiotherapy and remained free from any recurrences during follow-up.

Citations

Citations to this article as recorded by  
  • It's not all about the thyroid! Extrinsic and unusual pathology affecting the thyroid gland: A pictorial review
    Edward Walker, Shishir Karthik, Preetha Chengot, Sriram Vaidyanathan
    Clinical Imaging.2022; 85: 29.     CrossRef
Close layer
A Case of Hyalinizing Trabecular Adenoma of the Thyroid Gland.
Hyun Won Shin, Young Lyun Oh, Hye Won Jang, Ji In Lee, Sun Wook Kim, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee, Kwang Won Kim, Jae Hoon Chung
J Korean Endocr Soc. 2009;24(1):54-57.   Published online March 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.1.54
  • 2,279 View
  • 19 Download
  • 2 Crossref
AbstractAbstract PDF
Hyalinizing trabecular tumor is a rare benign thyroid tumor first described by Carney et al. in 1987. The tumor is characterized by an encapsulated nodule, trabecular arrangement of polygonal, oval, elongated cells, and hyalinized stroma. It is easily confused with papillary thyroid carcinoma or medullary thyroid carcinoma on surgical and cytologic specimens. A 45-year-old man presented with an incidentally detected left thyroid mass. Fine needle aspiration was performed and papillary thyroid carcinoma was suspected. However, the surgical specimen revealed a hyalinizing trabecular adenoma. We present this hyalinizing trabecular adenoma case to share our experience with physicians and specialists.

Citations

Citations to this article as recorded by  
  • A Case of Multifocal Hyalinizing Trabecular Tumors of the Thyroid Gland
    Suhwan Jeong, Hanaro Park
    Journal of Clinical Otolaryngology Head and Neck Surgery.2021; 32(3): 308.     CrossRef
  • A Case of Hyalinizing Trabecular Tumor of the Thyroid Gland
    Kun Woo Kim, Sang Joon Lee, Phil-Sang Chung, Junghwan Moon
    Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2012; 55(12): 795.     CrossRef
Close layer
A Case of Carcinoma Showing Thymus-Like Differentiation (CASTLE) in the Thyroid.
Eun Hee Kim, Ji Yun Jeong, Eui Young Kim, Sang Ah Lee, Kyung Min Kim, Ji Hye Yim, Won Gu Kim, Tae Yong Kim, Sun A Kim, Gyungyup Gong, Young Kee Shong, Won Bae Kim
J Korean Endocr Soc. 2008;23(4):272-276.   Published online August 1, 2008
DOI: https://doi.org/10.3803/jkes.2008.23.4.272
  • 1,962 View
  • 24 Download
  • 2 Crossref
AbstractAbstract PDF
Carcinoma Showing Thymus-Like Differentiation (CASTLE) is a very rare malignant neoplasm of the thyroid, and this resembles lymphoepithelioma or squamous cell carcinoma of the thymus. It originates from ectopic thymic tissue or remnants of the branchial pouches. We recently experienced a case of CASTLE in the thyroid gland of a 61-year-old woman. She presented with an asymptomatic mass in the right thyroid gland and she was diagnosed with 'poorly differentiated carcinoma' of the thyroid by fine needle aspiration cytology (FNAC). Total thyroidectomy was performed for both diagnostic and therapeutic purposes. Histologic examination of the resected tumor showed that the tumor was lobulated with expanding fibrous bands, and it was infiltrated by lymphocytes and plasma cells. The tumor cells had oval, large vesicular nuclei and prominent nucleoli, and the immunohistochemical staining was positive for CD5 and bcl-2, so the patient was diagnosed with thyroid CASTLE. We report here on a case of CASTLE in the thyroid gland treated by surgery and external neck radiation therapy.

Citations

Citations to this article as recorded by  
  • Intrathyroidal thymic carcinoma exhibiting neuroendocrine differentiation: Case report with cytomorphology, immunocytochemistry, and review of the literature focusing on cytology
    Wen‐hao Ren, Kun Dong, Xiao‐zheng Huang, Yan‐li Zhu
    Diagnostic Cytopathology.2019; 47(11): 1197.     CrossRef
  • Cytologic Findings of Thyroid Carcinoma Showing Thymus-like Differentiation: A Case Report
    Sunhee Chang, Mee Joo, Hanseong Kim
    Korean Journal of Pathology.2012; 46(3): 302.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP